Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125644931 | 12564493 | 1 | I | 20160308 | 20160718 | 20160718 | EXP | US-CIPLA LTD.-2016US07110 | CIPLA | 0.00 | Y | 0.00000 | 20160718 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125644931 | 12564493 | 1 | PS | WARFARIN SODIUM. | WARFARIN SODIUM | 1 | Oral | 5 MG ON TUESDAY AND FRIDAY, 1/2 TABLET OF 5 MG ON ALL OTHER DAY IN WEEK | U | 90935 | TABLET | ||||||||
125644931 | 12564493 | 2 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | Unknown | 50 UNK, UNK | U | U | 0 | 50 | UG | ||||||
125644931 | 12564493 | 3 | C | LOSARTAN. | LOSARTAN | 1 | Unknown | 50 MG, UNK | U | U | 0 | 50 | MG | ||||||
125644931 | 12564493 | 4 | C | PACERONE | AMIODARONE HYDROCHLORIDE | 1 | Unknown | 200 MG, UNK | U | U | 0 | 200 | MG | ||||||
125644931 | 12564493 | 5 | C | Bisoprolol+HCTZ | 2 | Unknown | 10/6.25 MG | U | U | 0 | |||||||||
125644931 | 12564493 | 6 | C | CLONAZEPAM. | CLONAZEPAM | 1 | Unknown | 0.5 MG, UNK | U | U | 0 | .5 | MG |
Indications of drugs used
no results found |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125644931 | 12564493 | International normalised ratio increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |